Phase II evaluation of docetaxel (D) plus exisulind (E) in patients (pts) with androgen independent prostate carcinoma (AIPC)
Year: 2005
Type: conference-abstract
Source: Journal of Clinical Oncology
Institution: Sidney Kimmel Comprehensive Cancer Center
Language: French
Subfield: Pulmonary and Respiratory Medicine
Field: Medicine
Domain: Health Sciences
Open Access status: closed
OpenAlex ID: W120494669
